Valeant to buy contact-lens giant Bausch & Lomb for $4.5 billion

LA Times - Valeant Pharmaceuticals International Inc., Canada's largest publicly traded drug maker, is continuing an acquisition spree with an agreement to buy eye-care giant Bausch & Lomb Holdings Inc. for $4.5 billion.  Read more.